KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Cash & Current Investments: 2009-2024

Historic Cash & Current Investments for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $194.6 million.

  • Charles River Laboratories International's Cash & Current Investments fell 1.46% to $207.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $813.9 million, marking a year-over-year decrease of 18.05%. This contributed to the annual value of $194.6 million for FY2024, which is 29.69% down from last year.
  • As of FY2024, Charles River Laboratories International's Cash & Current Investments stood at $194.6 million, which was down 29.69% from $276.8 million recorded in FY2023.
  • In the past 5 years, Charles River Laboratories International's Cash & Current Investments ranged from a high of $276.8 million in FY2023 and a low of $194.6 million during FY2024.
  • Over the past 3 years, Charles River Laboratories International's median Cash & Current Investments value was $233.9 million (recorded in 2022), while the average stood at $235.1 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first climbed by 18.32% in 2023, then declined by 29.69% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Cash & Current Investments (Yearly) stood at $228.4 million in 2020, then climbed by 5.60% to $241.2 million in 2021, then declined by 3.03% to $233.9 million in 2022, then increased by 18.32% to $276.8 million in 2023, then decreased by 29.69% to $194.6 million in 2024.